2022 Chemistry Laureate Carolyn Bertozzi Shares Inspiring Advice for Young Scientists
The Nobel Prize recently shared an encouraging post on LinkedIn:
”A personal message from 2022 chemistry laureate Carolyn Bertozzi to all young researchers on why to aspire to a career in science:
‘I would want to share with them how a life in science is incredibly rewarding. It is rewarding because it is creative. You are discovering knowledge and gifting that to humanity for all of posterity. Once you learn something no one can take that away. It is not an object. It is an intellectual currency that will be shared throughout the generations. And you created that. It has a permanence that ironically a physical object doesn’t have. You can paint a painting, but eventually it will fade. But knowledge doesn’t fade. Knowledge stays with us forever and it becomes the foundation for the next generations.’ ”
In this personal message to aspiring researchers, Nobel laureate Carolyn Bertozzi emphasized the creativity and lasting impact of a life in science.
She encourages young scientists to pursue discovery, highlighting that knowledge is a permanent gift to humanity, unlike physical creations that may fade over time.
Carolyn Bertozzi describes scientific knowledge as an intellectual currency that endures across generations, forming the foundation for future discoveries.
More winner stories in the field of Science featured in Hemostasis Today.
-
Sep 11, 2025, 08:33Alfonso J. Tafur Shares VascuLearn’s Free Virtual Support Groups This Fall for Patients and Providers
-
Sep 10, 2025, 23:00Blood Vessels, Thrombosis and Hemostasis - Blood VTH and Blood Neoplasia: Now Indexed in PubMed!
-
Sep 10, 2025, 13:00Shivani Modi Presents 7 Posters at SOHO 2025: From AI to Hematologic Emergencies
-
Sep 10, 2025, 09:27Deep Vein Thrombosis (DVT) Explained in One Slide: Causes, Symptoms, Diagnosis and Treatment
-
Sep 10, 2025, 09:20Giuseppe Biondi Zoccai Celebrates Release of New Book on Medical Statistics
-
Sep 12, 2025, 03:38Haematologica Early View: Omid Seidizadeh Explores Genetics Behind Clinical Variability in Type 2 VWD
-
Sep 11, 2025, 15:03Rapid ADAMTS13 Assays: A Key Milestone in the 100 Years of Innvoation in TTP Diagnosis - Silvio Castagni
-
Sep 11, 2025, 13:55Transplantation-Mediated Alloimmune Thrombocytopenia: Mostafa Faisal Mohammed Saleh Presents a Rare Case
-
Sep 10, 2025, 22:34Nicolas Gendron on The Emerging Role of CLIA in The Diagnosis Strategy for HIT
-
Sep 10, 2025, 21:13Gregory Piazza on The Link Between VTE and Atherothrombosis
-
Sep 9, 2025, 20:15Linking a Single Dominant Antibody to HIT: A Novel Study Led by Ishac Nazy, Donald Arnold, and John G. Kelton
-
Sep 8, 2025, 14:24Von Willebrand Factor as a Therapeutic Target․ From Development to Clinical Application
-
Sep 8, 2025, 02:35Reza Shojaei on the Real Worth of Hemoglobin Oxygen Carriers – HBOCs
-
Sep 7, 2025, 14:16Mary Kiige: Biological Hemoglobin Oxygen Carrier as a Lifesaving Oxygen Bridge
-
Sep 7, 2025, 14:13Breakthrough in Blood: Cécile Denis and INSERM Team Develop Nanobody Therapy for Type 1 VWD
-
Sep 11, 2025, 15:27Postpartum Haemorrhage: In Kenya, More than 120 Mothers Die for Every 100,000 Live Births
-
Sep 11, 2025, 08:08Al-Ola A Abdallah on MGUS-Related Bleeding Disorders
-
Sep 10, 2025, 19:32Denis Brutus Oduor: Call for Altruism in Blood Donation in Nairobi
-
Sep 9, 2025, 10:34James Douketis Receives the 2025 Distinguished Service Award in General Internal Medicine!
-
Sep 9, 2025, 08:07Hemophilia Federation of America Launches ‘Blood Brothers’ Podcast for Men With Bleeding Disorders